Skip to content

Medline, Inc. MDLN United States — Net Sales

Other financials

Income statement

See full
Revenue$7.4B+10.7%
Gross profit$1.8B+0.9%
Operating income$422.0M-26.1%
Net income$239.0M-25.1%
EPS (diluted)$0.16

Balance sheet

See full
Cash & equivalents$2.2B+166%
Total debt$12.6B
Total equity$11.3B
Total assets$39.0B

Cash flow

See full
Operating cash flow$412.0M-39.6%
CapEx$96.0M-2.0%
Free cash flow$316.0M-45.9%

Valuation

See full
Market cap$30.39B
Enterprise value$40.71B
P/E36.1×
P/S1.1×

Profitability

See full
Gross margin27.4%+1.5pp
Operating margin8.5%+2.3pp
Net margin4.6%+2.7pp

Returns & leverage

See full
Return on equity7.7%
Debt / equity1.1×
Current ratio4.4×

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's united states — net sales.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medline, Inc. 's united states — net sales?
Medline, Inc. (MDLN) reported united states — net sales of $6.86B in Q1 2026.
How has Medline, Inc. 's united states — net sales changed year-over-year?
Medline, Inc. 's united states — net sales increased by 10.7% year-over-year, from $6.19B to $6.86B.